Astria Therapeutics Receives Buy Rating Due to Promising Clinical Developments and Strategic Market Positioning
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Astria Therapeutics (ATXS – Research Report), with ...
BioPharma Dive4h
Ascentage prices first biotech IPO of 2025, raising $126M
The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.
Zacks.com on MSN14h
CYTK Stock Rises as Enrollment Begins in Phase II Heart Failure Study
Shares of Cytokinetics CYTK gained 2.2% on Wednesday after the company began enrolling patients in its mid-stage study of CK-4021586 (CK-586), a cardiac myosin inhibitor, for treating heart failure ...
Indiatimes9h
Natco Pharma Share Price
Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 22,532.02 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...
Indiatimes9h
Mankind Pharma Share Price
Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,11,586.97 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...